Analyzing search behavior of healthcare professionals for drug safety surveillance

Pacific Symposium on Biocomputing

Volumn , Issue , 2015, Pages 306-317

  Odgers, David J ^a   Harpaz, Rave ^a   Callahan, Alison ^a   Stiglic, Gregor ^b   Shah, Nigam H ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARIBOR   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

HEALTH CARE;

ADVERSE DRUG EVENTS; DISCRIMINATION ACCURACY; HEALTH CARE PROFESSIONALS; NEGATIVE CONTROL; PRELIMINARY ANALYSIS; RECEIVER OPERATOR CURVES; REFERENCE STANDARD; REPORTING SYSTEMS;

MONITORING;

ADVERSE DRUG REACTION; BIOLOGY; DRUG DATABASE; DRUG SURVEILLANCE PROGRAM; EVALUATION STUDY; HEALTH CARE PERSONNEL; HUMAN; INFORMATION PROCESSING; RECEIVER OPERATING CHARACTERISTIC; SEARCH ENGINE; STANDARD; STANDARDS; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

ADVERSE DRUG REACTION REPORTING SYSTEMS; COMPUTATIONAL BIOLOGY; DATA CURATION; DATABASES, PHARMACEUTICAL; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HEALTH PERSONNEL; HUMANS; MODELS, STATISTICAL; REFERENCE STANDARDS; ROC CURVE; SEARCH ENGINE;

EID: 84971255224     PISSN: 23356928     EISSN: 23356936     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (34)

1. Classen, D.C., et al., JAMA, 277 (4), 301 (1997).
2. Lazarou, J., B.H. Pomeranz, and P.N. Corey, JAMA, 279 (15), 1200 (1998).
3. Classen, D.C., et al., Health Aff (Millwood), 30 (4), 581 (2011).
4. Hug, B.L., et al., Jt Comm J Qual Patient Saf, 38 (3), 120 (2012).
5. Honig, P.K., Clin Pharmacol Ther, 93 (6), 474 (2013).
6. Harpaz, R., et al., Clin Pharmacol Ther, 91 (6), 1010 (2012).
7. Platt, R., et al., N Engl J Med, 361 (7), 645 (2009).
8. Stang, P.E., et al., Ann Intern Med, 153 (9), 600 (2010).
9. Levinson, D.R., Department of Health and Human Services, Available from http://oig.hhs.gov/oei/reports/oei-06-09-00091.pdf (2012).
10. Avorn, J. and S. Schneeweiss, N Engl J Med, 361 (7), 647 (2009).
11. Hauben, M. and A. Bate, Drug Discov Today, 14 (7-8), 343 (2009).
12. Schneeweiss, S., et al., Epidemiology, 20 (4), 512 (2009).
13. Coloma, P.M., et al., Pharmacoepidemiol Drug Saf, 21 (6), 611 (2012).
14. LePendu, P., et al., Clin Pharmacol Ther, 93 (6), 547 (2013).
15. Iyer, S.V., et al., J Am Med Inform Assoc, 21 (2), 353 (2014).
16. Yom-Tov, E. and E. Gabrilovich, J Med Internet Res, 15 (6), e124 (2013).
17. White, R.W., et al., J Am Med Inform Assoc, 20 (3), 404 (2013).
18. White, R.W., et al., Clin Pharmacol Ther, 96 (2), 239 (2014).
19. Freifeld, C.C., et al., Drug Saf, 37 (5), 343 (2014).
20. Shetty, K.D. and S.R. Dalal, JAMIA, 18 (5), 668 (2011).
21. Avillach, P., et al., J Am Med Inform Assoc, 20 (3), 446 (2013).
22. Pontes, H., M. Clement, and V. Rollason, Drug Saf, 37 (7), 471 (2014).
23. Harpaz, R., et al. KDD (2013).
24. Xu, R. and Q. Wang, BMC Bioinformatics, 15 (2014).
25. Bonis, P.A., et al., Int J Med Inform, 77 (11), 745 (2008).
26. Isaac, T., J. Zheng, and A. Jha, J Hosp Med, 7 (2), 85 (2012).
27. Lependu, P., et al., J Biomed Semantics, 3 Suppl 1 S5 (2012).
28. Lependu, P., et al., AMIA Jt Summits Transl Sci Proc, 2012 63 (2012).
29. Harpaz, R., et al., Clin Pharmacol Ther, 93 (6), 539 (2013).
30. Coloma, P.M., et al., Drug Safety, 36 (1), 13 (2013).
31. Harpaz, R., et al., Nature Scientific Data, In press (2014).
32. U. S. Food and Drug Administration. http://www.fda.gov/Safety/MedWatch/SafetyInformation/Safety-RelatedDrugLabelingChanges/default.htm (2014) [cited 2014 September 28].
33. U. S. Food and Drug Administration. http://www.accessdata.fda.gov/scripts/cder/drugsatfda/ (2014) [cited 2014 September 28].
34. Sarntivijai, S. and D.R. Abernethy, Clin Pharmacol Ther, 96 (2), 149 (2014).